Industry Pipeline - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Industry Pipeline
Interphex Showcase 2010.

Pharmaceutical Technology
Volume 34, Issue 4, pp. 128-135



Powder-induction system
Ross's In-line SLIM system is designed to improve powder induction in a liquid stream. The system's rotor–stator generator includes progressive spiral porting, which produces high flow, high shear, and a high level of vacuum. This feature enables the system to operate without a pump and induct powders quickly. Charles Ross and Son, Hauppauge, NY http://www.highshearmixers.com/ tel. 800.243.ROSS



Vial-filling system
The compact MHI vial filler is designed to meet the specific needs of clinical and pilot production programs by offering a flexible platform in a compact package. The MHI unit can support various filling technologies, thus providing the versatility to explore different filling options on one machine. Bosch, Minneapolis, MN http://www.boschpharma-us.com/ tel. 763.424.4700



Tablet-coating platform
The Accela-Cota FLEX 500 tablet-coating platform features six exchangeable drums and provides an overall batch-size range of 50–820 L. Innovative gun positioning, a segmented exhaust plenum, and interchangeable mixing baffles configure the coater according to the requirements of the batch size and coating processes. Thomas Engineering, Hoffman Estates, IL http://www.thomaseng.com/ tel. 800.634.9910



Growth-media sterilization systems
ABC Actini manufactures and engineers a range of growth-media sterilization systems to meet stringent standards. The company's systems incorporate fully aseptic heat exchangers, single-pass systems, gravity drainability, high-purity seamless tubing, and a safe, indirect energy-recovery section. The systems are designed according to current good manufacturing practice and perform continuous treatment. ABC Actini, Lewis Run, PA http://www.abc-actini.com/ tel. 888.278.8544



Process valves
GEMÜ offers a broad range of aseptic diaphragm valves and multiport valves that comply with the US Food and Drug Administration's and the US Pharmacopeia's regulations. Automation options include communication and control modules that facilitate commissioning and optimize the diagnostic benefits of control-network architecture. GEMÜ Valves and Instrumentation, Atlanta, GA http://www.gemu.com/ tel. 678.553.3400


ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
How does your company apply quality-by-design (QbD) principles to manufacturing processes?
To all processes for both new and legacy products
To all process for new products only
To select process for new products only
To select processes for both new and legacy products
Do not use QbD
To all processes for both new and legacy products
21%
To all process for new products only
13%
To select process for new products only
26%
To select processes for both new and legacy products
21%
Do not use QbD
21%
View Results
UPCOMING CONFERENCES

Programs for Investigational and Pre-Launch Drugs
Philadelphia, PA
July 17-18, 2013
Request Brochure

Strategic Pipeline Planning & Portfolio Valuation
Philadelphia, PA
August 13-14, 2013
Request Brochure

MES 2013 - Forum on Manufacturing Execution Systems
Philadelphia, PA
August 14-15, 2013
Request Brochure

Mobile Innovation for the Life Sciences Industry
Philadelphia, PA
August 20-21, 2013
Request Brochure

See All Conferences >>

Eric Langer Outsourcing Outlook Eric LangerOutsourcing's Modest Role as a Cost-Containment Strategy
Patricia Van Arnum Ingredients Insider Patricia Van ArnumIntellectual Property Battles in Solid-State Chemistry
Nathan Jessop Industry Insider Nathan Jessop Campaign Against Counterfeit Drugs Continues
Lynn Torbeck Statistical Solutions Lynn D. TorbeckCompositing Samples and the Risk to Product Quality
 More
Global Biosimilars Market to Reach $2.445 Billion in 2013
Adapting to Change
AstraZeneca and Exco InTouch Collaborate to Augment Current COPD Pathways
Overcoming the Challenges in Biopharmaceutical Stability Testing
PhRMA Dismayed by Special 301 Report
FindPharma Custom Search
Source: Pharmaceutical Technology,
Click here